SEHK:6990
SEHK:6990Biotechs

A Look At Sichuan Kelun Biotech (SEHK:6990) Valuation After New Breakthrough Therapy And IND Approvals

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has drawn fresh investor attention after China’s regulator granted Breakthrough Therapy Designation for sacituzumab tirumotecan with pembrolizumab in first line PD-L1-positive lung cancer, alongside IND approval for SKB105 in advanced solid tumors. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The latest regulatory milestones appear to be feeding into strong momentum, with a 1-day share price return of 2.64%, a 7-day...
SEHK:2259
SEHK:2259Metals and Mining

Asian Value Stocks Trading Below Estimated Worth In January 2026

As we enter 2026, Asian markets are capturing global attention with their robust performance, driven by optimism in the tech sector and a resurgence in consumer spending. Amidst this momentum, investors are increasingly looking for value stocks—those trading below their estimated worth—that could offer potential opportunities within this thriving economic landscape.
SEHK:6090
SEHK:6090Personal Products

Uncovering Undiscovered Gems In Asia January 2026

As we enter 2026, the Asian markets are capturing global attention with strong performances, particularly in the small-cap segment, echoing trends seen in other regions where small-cap and value shares have outpaced their larger counterparts. In this dynamic environment, identifying promising stocks involves looking for those with solid fundamentals and growth potential that can thrive amid current economic indicators and evolving market sentiments.